[Cut-off level of glycosylated hemoglobin indicating the development of complications in type 2 diabetes mellitus].
Cristoforo Incorvaia, Franco Maraffi, Raffaella Megali, F. Nitti, Mario Fumagalli
Abstract
Cristoforo Incorvaia, Franco Maraffi, Raffaella Megali, F. Nitti, Mario Fumagalli
Abstract
Prevention of chronic complications is very important in the management of type 2 diabetes, and the availability of a laboratory test individuating at risk subjects should have a marked usefulness. This study sought by the method of ROC curves the cut-off of glycated haemoglobin discriminating the subjects with microvascular, neurologic and renal complications from those without. The cut-off was identified at a glycated haemoglobin level of 7.95, showing a sensitivity of 74.8% and a specificity of 73.3%, which makes it a possible tool for evaluating the risk of complications in type 2 diabetes.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Prevention of chronic complications is very important in the management of type 2 diabetes, and the availability of a laboratory test individuating at risk subjects should have a marked usefulness. This study sought by the method of ROC curves the cut-off of glycated haemoglobin discriminating the subjects with microvascular, neurologic and renal complications from those without. The cut-off was identified at a glycated haemoglobin level of 7.95, showing a sensitivity of 74.8% and a specificity of 73.3%, which makes it a possible tool for evaluating the risk of complications in type 2 diabetes.
Key concepts: Glycated hemoglobin, Medicine, Glycated haemoglobin, Diabetes mellitus, Type 2 Diabetes Mellitus, Internal medicine, Hemoglobin, Type 2 diabetes